Clinical Trial Update: Treatment of Elevated Arterial Pulmonary Pressure With Inhaled Iloprost [NA]

View source ↗

Summary

A clinical trial evaluating inhaled iloprost for elevated arterial pulmonary pressure has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Persistent Pulmonary Hypertension of the Newborn
• Respiratory Distress Syndrome

Drugs mentioned

• Iloprost (inhaled) (Iloprost)

Snippet

Sponsor: Lund University Hospital | Conditions: Persistent Pulmonary Hypertension, Respiratory Distress Syndrome | NA | Status: WITHDRAWN